Investment Update: Biocryst Pharmaceuticals & Xeris Pharmaceuticals

from BioBreak Podcast by MS Money Moves · host MS Money Moves

Here we overview updates to a our core position holding Biocryst Pharmaceuticals (NASDAQ: BCRX). This article was originally published exclusively for subscribers on September 9th, 2020. Listen and learn more about our thoughts on Biocryst. We also delve into a subscriber question on Xeris Pharmaceuticals (NASDAQ: XERS). Want exclusive access to these articles when they first come out? Visit www.msmoneymoves.com and subscribe today!

Episode metadata supplied by the publisher feed · Published Sep 22, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Investment Update: Biocryst Pharmaceuticals & Xeris Pharmaceuticals

0:00 13:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBreak Podcast by MS Money Moves?

This episode is 13 minutes long.

When was this BioBreak Podcast by MS Money Moves episode published?

This episode was published on September 22, 2020.

Can I download this BioBreak Podcast by MS Money Moves episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!